Barclays Downgrades Qiagen NV (QGEN) to Equalweight
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $44.21 +1.89%
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
Barclays downgraded Qiagen NV (NASDAQ: QGEN) from Overweight to Equalweight with a price target of $19.00 (from $21.00).
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $19.88 yesterday.
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $19.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- Palo Alto Networks (PANW) PT Raised to $420 at DA Davidson on Strong Q4 Upside
- Dell (DELL) PT Raised to $635 at JPMorgan on Robust Q2 Results
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
